While no single indicator can guarantee a stock's performance, the pattern of insider transactions can provide a powerful glimpse into a company's prospects.
Viking Therapeutics, Inc. VKTX is pressing ahead in the weight-loss drug race with the launch of its Phase 2 VENTURE-Oral trial to test a daily pill version of VK2735 in obese and overweight adults, a
Healthcare has been one of the toughest sectors for investors over the past year. In fact, over the last 12 months, it has been the worst performing sector in the entire market.
Eli Lilly launched the pre-filled injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees (nearly $160) for its starting dose of 2.5 mg in India on Wednesday, stepping up competiti
After Eli Lilly & Co. shares fell sharply in the wake of disappointing trial data for its weight-loss pill, several of its executives and board members saw an opportunity to buy.

Final Trade: LLY, ULTA, AAPL, GDX

06:23pm, Tuesday, 12'th Aug 2025
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly "bribing" providers to prescribe its medications.
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Affirm Holdings Inc AFRM is a buy. “It's at $72, it's going to $100,” he noted.
From late 2020 to the summer of 2024, Eli Lilly & Co. (NYSE: LLY) stock was on a tear, up more than 635%.
I see Las Vegas' struggles as a mirror of broader economic woes of high prices, low consumer confidence, and trade uncertainty, pressuring markets and creating slim margins for error. I believe market

Why Eli Lilly Stock Popped Today

03:48pm, Monday, 11'th Aug 2025
Shares of Eli Lilly (LLY 1.49%), the pharmaceuticals giant and maker of the Mounjaro and Zepbound weight loss drugs, saw its stock bounce back a modest 2.5% through 1:55 p.m. ET Monday on some positiv
LLY's orforglipron study results disappoint, shifting investor focus to Novo Nordisk's bid for first FDA-approved oral obesity pill.
Explore Lilly's (LLY) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.

Eli Lilly: Another Not-To-Miss Dip

11:08am, Saturday, 09'th Aug 2025
Eli Lilly's price fell with a thud yesterday following underwhelming drug trial results as the markets completely ignored strong Q2 2025 results. LLY's drop is immediately reminiscent of a similar plu
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE